APO Research

APO RESEARCH · REPORT

Pet Intestinal Medicine

Selected research

Industry Growth & Trends

Global Pet Intestinal Medicine Industry Growth and Trends Forecast to 2032

Market perspective

The global Pet Intestinal Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Intestinal Medicine include Boehringer Ingelheim, CAHIC, Ceva, Dechra Veterinary Products, Elanco, Jindun, Norbrook, Ouro Fino Saude and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pet Intestinal Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pet Intestinal Medicine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Intestinal Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Intestinal Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pet Intestinal Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pet Intestinal Medicine Market by Company

Boehringer Ingelheim

CAHIC

Ceva

Dechra Veterinary Products

Elanco

Jindun

Norbrook

Ouro Fino Saude

Vetoquinol

Virbac

Wuhan chopperlvya

Merck

Zoetis

Pet Intestinal Medicine Segment by Type

Powder

Liquid

Pet Intestinal Medicine Segment by Application

Reptile

Cat

Dog

Other

Pet Intestinal Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Intestinal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Intestinal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Intestinal Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Intestinal Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pet Intestinal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Liquid Table 3. Global Pet Intestinal Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 5. Global Pet Intestinal Medicine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pet Intestinal Medicine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pet Intestinal Medicine Sales Market Share in Value by Type (2021-2026) Table 8. Global Pet Intestinal Medicine Price by Type (2021-2026) & (US$/unit) Table 9. Global Pet Intestinal Medicine Sales by Type (2027-2032) & (k units) Table 10. Global Pet Intestinal Medicine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pet Intestinal Medicine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pet Intestinal Medicine Sales Market Share in Value by Type (2027-2032) Table 13. Global Pet Intestinal Medicine Price by Type (2027-2032) & (US$/unit) Table 14. North America Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 15. North America Pet Intestinal Medicine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 17. Europe Pet Intestinal Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Pet Intestinal Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 21. Latin America Pet Intestinal Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Pet Intestinal Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Pet Intestinal Medicine Industry Trends Table 25. Pet Intestinal Medicine Industry Drivers Table 26. Pet Intestinal Medicine Industry Opportunities and Challenges Table 27. Pet Intestinal Medicine Industry Restraints Table 28. Global Pet Intestinal Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pet Intestinal Medicine Revenue Market Share by Company (2021-2026) Table 30. Global Pet Intestinal Medicine Sales by Company (2021-2026) & (k units) Table 31. Global Pet Intestinal Medicine Sales Share by Company (2021-2026) Table 32. Global Pet Intestinal Medicine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Pet Intestinal Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pet Intestinal Medicine Major Company Production Sites and Headquarters Table 35. Global Pet Intestinal Medicine Company, Product Type & Application Table 36. Global Pet Intestinal Medicine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pet Intestinal Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pet Intestinal Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pet Intestinal Medicine Sales by Region (2021-2026) & (k units) Table 41. Global Pet Intestinal Medicine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pet Intestinal Medicine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pet Intestinal Medicine Sales Market Share in Value by Region (2021-2026) Table 44. Global Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Pet Intestinal Medicine Sales by Region (2027-2032) & (k units) Table 46. Global Pet Intestinal Medicine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pet Intestinal Medicine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pet Intestinal Medicine Sales Market Share in Value by Region (2027-2032) Table 49. Global Pet Intestinal Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Pet Intestinal Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 52. Global Pet Intestinal Medicine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pet Intestinal Medicine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pet Intestinal Medicine Sales Market Share in Value by Application (2021-2026) Table 55. Global Pet Intestinal Medicine Price by Application (2021-2026) & (US$/unit) Table 56. Global Pet Intestinal Medicine Sales by Application (2027-2032) & (k units) Table 57. Global Pet Intestinal Medicine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pet Intestinal Medicine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pet Intestinal Medicine Sales Market Share in Value by Application (2027-2032) Table 60. Global Pet Intestinal Medicine Price by Application (2027-2032) & (US$/unit) Table 61. North America Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 62. North America Pet Intestinal Medicine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 64. Europe Pet Intestinal Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Pet Intestinal Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 68. Latin America Pet Intestinal Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Pet Intestinal Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. CAHIC Company Information Table 77. CAHIC Business Overview Table 78. CAHIC Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CAHIC Pet Intestinal Medicine Product Portfolio Table 80. CAHIC Recent Development Table 81. Ceva Company Information Table 82. Ceva Business Overview Table 83. Ceva Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Ceva Pet Intestinal Medicine Product Portfolio Table 85. Ceva Recent Development Table 86. Dechra Veterinary Products Company Information Table 87. Dechra Veterinary Products Business Overview Table 88. Dechra Veterinary Products Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio Table 90. Dechra Veterinary Products Recent Development Table 91. Elanco Company Information Table 92. Elanco Business Overview Table 93. Elanco Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Elanco Pet Intestinal Medicine Product Portfolio Table 95. Elanco Recent Development Table 96. Jindun Company Information Table 97. Jindun Business Overview Table 98. Jindun Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Jindun Pet Intestinal Medicine Product Portfolio Table 100. Jindun Recent Development Table 101. Norbrook Company Information Table 102. Norbrook Business Overview Table 103. Norbrook Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Norbrook Pet Intestinal Medicine Product Portfolio Table 105. Norbrook Recent Development Table 106. Ouro Fino Saude Company Information Table 107. Ouro Fino Saude Business Overview Table 108. Ouro Fino Saude Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Ouro Fino Saude Pet Intestinal Medicine Product Portfolio Table 110. Ouro Fino Saude Recent Development Table 111. Vetoquinol Company Information Table 112. Vetoquinol Business Overview Table 113. Vetoquinol Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Vetoquinol Pet Intestinal Medicine Product Portfolio Table 115. Vetoquinol Recent Development Table 116. Virbac Company Information Table 117. Virbac Business Overview Table 118. Virbac Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Virbac Pet Intestinal Medicine Product Portfolio Table 120. Virbac Recent Development Table 121. Wuhan chopperlvya Company Information Table 122. Wuhan chopperlvya Business Overview Table 123. Wuhan chopperlvya Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio Table 125. Wuhan chopperlvya Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Merck Pet Intestinal Medicine Product Portfolio Table 130. Merck Recent Development Table 131. Zoetis Company Information Table 132. Zoetis Business Overview Table 133. Zoetis Pet Intestinal Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Zoetis Pet Intestinal Medicine Product Portfolio Table 135. Zoetis Recent Development Table 136. North America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 138. North America Pet Intestinal Medicine Sales Market Share by Country (2021-2026) Table 139. North America Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Pet Intestinal Medicine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Pet Intestinal Medicine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Pet Intestinal Medicine Market Share by Country (2021-2026) Table 144. North America Pet Intestinal Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Pet Intestinal Medicine Market Share Forecast by Country (2027-2032) Table 146. Europe Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 148. Europe Pet Intestinal Medicine Sales Market Share by Country (2021-2026) Table 149. Europe Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Pet Intestinal Medicine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Pet Intestinal Medicine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Pet Intestinal Medicine Market Share by Country (2021-2026) Table 154. Europe Pet Intestinal Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Pet Intestinal Medicine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Pet Intestinal Medicine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Pet Intestinal Medicine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Pet Intestinal Medicine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Pet Intestinal Medicine Market Share by Country (2021-2026) Table 164. Asia-Pacific Pet Intestinal Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Pet Intestinal Medicine Market Share Forecast by Country (2027-2032) Table 166. Latin America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 168. Latin America Pet Intestinal Medicine Sales Market Share by Country (2021-2026) Table 169. Latin America Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Pet Intestinal Medicine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Pet Intestinal Medicine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Pet Intestinal Medicine Market Share by Country (2021-2026) Table 174. Latin America Pet Intestinal Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Pet Intestinal Medicine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Pet Intestinal Medicine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Pet Intestinal Medicine Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Pet Intestinal Medicine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Pet Intestinal Medicine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Pet Intestinal Medicine Market Share by Country (2021-2026) Table 184. Middle East and Africa Pet Intestinal Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Pet Intestinal Medicine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Pet Intestinal Medicine Distributors List Table 189. Pet Intestinal Medicine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Pet Intestinal Medicine Image Figure 2. Global Pet Intestinal Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Intestinal Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Intestinal Medicine Sales (2021-2032) & (k units) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (k units) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Pet Intestinal Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pet Intestinal Medicine Market Share by Type 2025 VS 2032 Figure 11. North America Pet Intestinal Medicine Sales Market Share in Volume by Type in 2025 Figure 12. North America Pet Intestinal Medicine Sales Market Share in Value by Type in 2025 Figure 13. Europe Pet Intestinal Medicine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pet Intestinal Medicine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pet Intestinal Medicine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pet Intestinal Medicine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pet Intestinal Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pet Intestinal Medicine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pet Intestinal Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pet Intestinal Medicine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pet Intestinal Medicine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Reptile Image Figure 24. Global Reptile Sales YoY Growth (2021-2032) & (k units) Figure 25. Cat Image Figure 26. Global Cat Sales YoY Growth (2021-2032) & (k units) Figure 27. Dog Image Figure 28. Global Dog Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Pet Intestinal Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pet Intestinal Medicine Market Share by Application 2025 VS 2032 Figure 33. North America Pet Intestinal Medicine Sales Market Share in Volume by Application in 2025 Figure 34. North America Pet Intestinal Medicine Sales Market Share in Value by Application in 2025 Figure 35. Europe Pet Intestinal Medicine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pet Intestinal Medicine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pet Intestinal Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pet Intestinal Medicine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pet Intestinal Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pet Intestinal Medicine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pet Intestinal Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pet Intestinal Medicine Sales Market Share in Value by Application in 2025 Figure 43. North America Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Pet Intestinal Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pet Intestinal Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Pet Intestinal Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pet Intestinal Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Pet Intestinal Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pet Intestinal Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Pet Intestinal Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pet Intestinal Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pet Intestinal Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Pet Intestinal Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pet Intestinal Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pet Intestinal Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pet Intestinal Medicine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pet Intestinal Medicine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Reptile
  • Cat
  • Dog
  • Other
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • Dechra Veterinary Products
  • Elanco
  • Jindun
  • Norbrook
  • Ouro Fino Saude
  • Vetoquinol
  • Virbac
  • Wuhan chopperlvya
  • Merck
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Intestinal Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pet Intestinal Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pet Intestinal Medicine Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Liquid
  8. 1.4 Global Pet Intestinal Medicine Market Size by Type
  9. 1.4.1 Global Pet Intestinal Medicine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pet Intestinal Medicine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pet Intestinal Medicine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pet Intestinal Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pet Intestinal Medicine Industry Trends
  2. 2.2 Pet Intestinal Medicine Industry Drivers
  3. 2.3 Pet Intestinal Medicine Industry Opportunities and Challenges
  4. 2.4 Pet Intestinal Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pet Intestinal Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pet Intestinal Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Pet Intestinal Medicine Price (2021-2026)
  4. 3.4 Global Pet Intestinal Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Intestinal Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Pet Intestinal Medicine Company, Product Type & Application
  7. 3.7 Global Pet Intestinal Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Intestinal Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Intestinal Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Intestinal Medicine Tier 1, Tier 2, and Tier 3
4 Pet Intestinal Medicine Regional Status and Outlook
  1. 4.1 Global Pet Intestinal Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pet Intestinal Medicine Historic Market Size by Region
  3. 4.2.1 Global Pet Intestinal Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pet Intestinal Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pet Intestinal Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pet Intestinal Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Pet Intestinal Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pet Intestinal Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pet Intestinal Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Intestinal Medicine by Application
  1. 5.1 Pet Intestinal Medicine Market by Application
  2. 5.1.1 Reptile
  3. 5.1.2 Cat
  4. 5.1.3 Dog
  5. 5.1.4 Other
  6. 5.2 Global Pet Intestinal Medicine Market Size by Application
  7. 5.2.1 Global Pet Intestinal Medicine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pet Intestinal Medicine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pet Intestinal Medicine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pet Intestinal Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 CAHIC
  8. 6.2.1 CAHIC Company Information
  9. 6.2.2 CAHIC Business Overview
  10. 6.2.3 CAHIC Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CAHIC Pet Intestinal Medicine Product Portfolio
  12. 6.2.5 CAHIC Recent Developments
  13. 6.3 Ceva
  14. 6.3.1 Ceva Company Information
  15. 6.3.2 Ceva Business Overview
  16. 6.3.3 Ceva Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ceva Pet Intestinal Medicine Product Portfolio
  18. 6.3.5 Ceva Recent Developments
  19. 6.4 Dechra Veterinary Products
  20. 6.4.1 Dechra Veterinary Products Company Information
  21. 6.4.2 Dechra Veterinary Products Business Overview
  22. 6.4.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio
  24. 6.4.5 Dechra Veterinary Products Recent Developments
  25. 6.5 Elanco
  26. 6.5.1 Elanco Company Information
  27. 6.5.2 Elanco Business Overview
  28. 6.5.3 Elanco Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Elanco Pet Intestinal Medicine Product Portfolio
  30. 6.5.5 Elanco Recent Developments
  31. 6.6 Jindun
  32. 6.6.1 Jindun Company Information
  33. 6.6.2 Jindun Business Overview
  34. 6.6.3 Jindun Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jindun Pet Intestinal Medicine Product Portfolio
  36. 6.6.5 Jindun Recent Developments
  37. 6.7 Norbrook
  38. 6.7.1 Norbrook Company Information
  39. 6.7.2 Norbrook Business Overview
  40. 6.7.3 Norbrook Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Norbrook Pet Intestinal Medicine Product Portfolio
  42. 6.7.5 Norbrook Recent Developments
  43. 6.8 Ouro Fino Saude
  44. 6.8.1 Ouro Fino Saude Company Information
  45. 6.8.2 Ouro Fino Saude Business Overview
  46. 6.8.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ouro Fino Saude Pet Intestinal Medicine Product Portfolio
  48. 6.8.5 Ouro Fino Saude Recent Developments
  49. 6.9 Vetoquinol
  50. 6.9.1 Vetoquinol Company Information
  51. 6.9.2 Vetoquinol Business Overview
  52. 6.9.3 Vetoquinol Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Vetoquinol Pet Intestinal Medicine Product Portfolio
  54. 6.9.5 Vetoquinol Recent Developments
  55. 6.10 Virbac
  56. 6.10.1 Virbac Company Information
  57. 6.10.2 Virbac Business Overview
  58. 6.10.3 Virbac Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Virbac Pet Intestinal Medicine Product Portfolio
  60. 6.10.5 Virbac Recent Developments
  61. 6.11 Wuhan chopperlvya
  62. 6.11.1 Wuhan chopperlvya Company Information
  63. 6.11.2 Wuhan chopperlvya Business Overview
  64. 6.11.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio
  66. 6.11.5 Wuhan chopperlvya Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Pet Intestinal Medicine Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Zoetis
  74. 6.13.1 Zoetis Company Information
  75. 6.13.2 Zoetis Business Overview
  76. 6.13.3 Zoetis Pet Intestinal Medicine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zoetis Pet Intestinal Medicine Product Portfolio
  78. 6.13.5 Zoetis Recent Developments
7 North America by Country
  1. 7.1 North America Pet Intestinal Medicine Sales by Country
  2. 7.1.1 North America Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pet Intestinal Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pet Intestinal Medicine Market Size by Country
  6. 7.2.1 North America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pet Intestinal Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pet Intestinal Medicine Sales by Country
  2. 8.1.1 Europe Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pet Intestinal Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pet Intestinal Medicine Market Size by Country
  6. 8.2.1 Europe Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pet Intestinal Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pet Intestinal Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pet Intestinal Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pet Intestinal Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pet Intestinal Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pet Intestinal Medicine Sales by Country
  2. 10.1.1 South America Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pet Intestinal Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pet Intestinal Medicine Market Size by Country
  6. 10.2.1 South America Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pet Intestinal Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pet Intestinal Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Pet Intestinal Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pet Intestinal Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pet Intestinal Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pet Intestinal Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Pet Intestinal Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pet Intestinal Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pet Intestinal Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pet Intestinal Medicine Value Chain Analysis
  2. 12.1.1 Pet Intestinal Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pet Intestinal Medicine Production Mode & Process
  7. 12.2 Pet Intestinal Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pet Intestinal Medicine Distributors
  10. 12.2.3 Pet Intestinal Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research